Renal-Cell Carcinoma | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Context Eosinophilic renal neoplasms include a spectrum of solid and papillary tumors
ranging from indolent benign oncocytoma to highly aggressive malignancies. Recognition of …

The aggregate literature suggests that chromophobe renal cell carcinoma (RCC) is
biologically a tumor of low malignant potential with reported 5-year and 10-year survival …

Despite multiple studies, many clinicopathologic issues about chromophobe renal cell
carcinoma (RCC) remain contentious; for example, its biological behavior-whether better or …

This study was undertaken to assess the prognostic effectiveness of Fuhrman nuclear
grading and the individual components of this grading system, in a series of chromophobe …

Background The purpose of the study was to evaluate clinical features and prognostic
factors in a large single institutional cohort of chromophobe renal cell carcinoma (ChRCC) …

OBJECTIVES: To analyze the clinical behavior of chromophobe renal cell carcinoma
(CRCC), we retrospectively evaluated the data from six European centers. In 1985, CRCC …

The category of globally accepted neoplasms of the kidney continues to expand.
Recognition of new entities is very important for care of patients and their families. For …

Background Targeted therapies have shown profound effects on the outcome of patients
with advanced renal cell carcinoma (RCC). However, the optimal treatment for RCC of non …

Renal cell carcinoma (RCC) is a malignancy that in advanced disease, is highly resistant to
systemic therapies. Elucidation of the angiogenesis pathways and their intrinsic signaling …